Testing effectiveness (Phase 2)Study completedNCT00135135What this trial is testingTherapy for Children With NeuroblastomaWho this might be right forNeuroblastoma St. Jude Children's Research Hospital 23
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078What this trial is testingIrinotecan in Treating Children With Refractory Solid TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more Children's Oncology Group 181
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Early research (Phase 1)Study completedNCT00101270What this trial is testingOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00006102What this trial is testingRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more National Cancer Institute (NCI) 200
Early research (Phase 1)Study completedNCT03936465What this trial is testingStudy of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric CancerWho this might be right forSolid Tumor, ChildhoodLymphomaBrain Tumor, Pediatric Dana-Farber Cancer Institute 41
Early research (Phase 1)Study completedNCT00003750What this trial is testingBiological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsWho this might be right forMelanoma (Skin)NeuroblastomaSarcoma+1 more Children's Oncology Group 28
Testing effectiveness (Phase 2)UnknownNCT00281905What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00003661What this trial is testingChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Roswell Park Cancer Institute 3
Testing effectiveness (Phase 2)Looking for participantsNCT06528496What this trial is testingN10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaWho this might be right forHigh-risk NeuroblastomaNeuroblastomaChildhood Neuroblastoma Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00939770What this trial is testingCrizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaWho this might be right forRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Malignant Solid NeoplasmRecurrent Neuroblastoma+3 more Children's Oncology Group 122
Early research (Phase 1)Study completedNCT00077454What this trial is testingErlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsWho this might be right forPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more National Cancer Institute (NCI) 95
Not applicableStudy completedNCT01802567What this trial is testingMolecular-Guided Therapy for Relapsed and Refractory Childhood CancerWho this might be right forNeuroblastomaMedulloblastomaBrain Tumors+1 more Giselle Sholler 52
Large-scale testing (Phase 3)Study completedNCT00003883What this trial is testingItraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 578
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT04897880What this trial is testingPanobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRTWho this might be right forRhabdoid TumorAtypical Teratoid/Rhabdoid TumorMalignant Rhabdoid Tumor+1 more Australian & New Zealand Children's Haematology/Oncology Group 25
Large-scale testing (Phase 3)Ended earlyNCT01987596What this trial is testingStudy of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With CancerWho this might be right forChildhood Choroid Plexus TumorChildhood MedulloblastomaChildhood Pineoblastoma+8 more Barbara Ann Karmanos Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00004157What this trial is testingInterleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsWho this might be right forBreast CancerGestational Trophoblastic TumorKidney Cancer+5 more Fred Hutchinson Cancer Center